Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Effects of electroconvulsive shock on noradrenergic and serotonergic receptors and their associated second messenger systems

Thesis/Dissertation ·
OSTI ID:5398581

This thesis confirmed previous findings that repeated administration of electroconvulsive shock (ECS) increases alpha-1 adrenoceptors labeled by {sup 3}H-prazosin in rat fronto-parietal cortex. On the other hand, {sup 3}-WB4101 binding was unaffected by ECS treatment. {sup 3}H-prazosin labels two subtypes of alpha-1 adrenergic receptors with equal affinity. These subtypes are discriminated in the basis of their affinities for the antagonist WB4101. The subtype with high affinity for WB4101 has been termed alpha-1a, while that with lower affinity has been termed alpha-1b. Hence, when 60 nM prazosin is used to define specific binding, {sup 3} H-WB4101 labels primarily the alpha-1a adrenoceptor. When WB4101 was included in {sup 3}H-prazosin binding experiments at concentrations which mask the alpha-1a adrenoceptor, the fractional increase in binding caused by ESC was significantly higher. These findings indicate that ECS selectively increases the alpha-1b adrenoceptor subtype in rat cortex. Similarly, chronic administration of reserpine appears to increase predominantly the alpha-1b adrenoceptor since this treatment increases {sup 3} H-prazosin, but not {sup 3}H-WB4101 binding in rat frontoparietal cortex. Quantitative autoradiography confirms and extends the above homogenate binding studies. Analysis of autoradiograms from ECS treated animals show that alpha-1b adrenoceptors are increased in most cortical areas of the brain. Interestingly, alpha-1a adrenoceptors appear to be increased only in the amygdaloid nuclei. Chronic treatment with reserpine results in increases in {sup 3}H-prazosin binding in the cortex, thalamus, and ventral hippocampus whereas {sup 3}H-WB4101 binding is not altered in any of the brain regions surveyed.

Research Organization:
Georgetown Univ. Medical Center, Washington, DC (United States)
OSTI ID:
5398581
Country of Publication:
United States
Language:
English